William Pedranti
AeroLeads people directory · profile

William Pedranti Email & Phone Number

Chief Executive Officer at Visgenx
Location: Ladera Ranch, California, United States 13 work roles 2 schools
1 work email found @scilexpharma.com 15 phones found area 949, 202, 714, 760, 310, 610, and 484 LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 15 phones

Work email w****@scilexpharma.com
Direct phone (949) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Executive Officer
Location
Ladera Ranch, California, United States
Company size

Who is William Pedranti? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

William Pedranti is listed as Chief Executive Officer at Visgenx, a with 7 employees, based in Ladera Ranch, California, United States. AeroLeads shows a work email signal at scilexpharma.com, phone signal with area code 949, 202, 714, 760, 310, 610, 484, and a matched LinkedIn profile for William Pedranti.

William Pedranti previously worked as Co-Founder and Partner at Peng Life Science Ventures and Co-Founder & Board Member at Iacta Pharmaceuticals. William Pedranti holds Jd, Law from Georgetown University Law Center.

Company email context

Email format at Visgenx

This section adds company-level context without repeating William Pedranti's masked contact details.

{first_initial}{last}@scilexpharma.com
86% confidence

AeroLeads found 1 current-domain work email signal for William Pedranti. Compare company email patterns before reaching out.

Profile bio

About William Pedranti

Possible summary:As the CEO of Visgenx, Mr. Pedranti is leading the development of innovative gene therapies for degenerative retinal disorders, such as age-related macular degeneration. He has over 20 years of experience in the biotech and pharmaceutical industry, spanning from R&D and clinical development to corporate strategy and business development.Prior to joining Visgenx, he co-founded and is a partner at PENG Life Science Ventures, a venture firm that supports entrepreneurs and visionaries in transforming the healthcare and life sciences sector. He has been involved in raising over $375 million in capital and negotiating transactions worth over $1 billion, including the sale of products and companies. He also co-founded and served as the president of operations at Scilex Pharmaceuticals, where he took a product from its inception to FDA approval and commercial launch. He holds a B.S. in Business Administration from USC and a J.D. from Georgetown.

Listed skills include Mergers And Acquisitions, Intellectual Property, Licensing, Corporate Governance, and 22 others.

Current workplace

William Pedranti's current company

Company context helps verify the profile and gives searchers a useful next step.

Visgenx
Visgenx
Chief Executive Officer
Ladera Ranch, CA, US
Website
Employees
7
AeroLeads page
13 roles

William Pedranti work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer

Ladera Ranch, Ca, Us

Chief Executive Officer

Current

Santa Cruz, California, Us

Developing gene therapy for degenerative retinal disorders.

May 2023 - Present

Co-Founder And Partner

Current
Peng Life Science Ventures

PENG Life Science Ventures (PENG LSV) is an independent and forward-thinking healthcare and life sciences venture firm. Our firm has started and invested in multiple companies in various therapeutic areas including oncology, ophthalmology, infectious disease, neurology and nephrology. We have taken a company from co-founding, through clinical development, product approval, commercial launch and then subsequent sale. Our goal is to support entrepreneurs and visionaries in taking their companies to the next level and transforming industries. Our founders have decades of experience in founding and leading companies through financings, transactions, transitions, development (both R&D and clinical) and commercialization. We can provide seed capital, collaborative support and advisory services in multiple, critical areas, including corporate development, strategy, logistics, clinical development, commercial readiness, manufacturing, business development and capital raises. In this regard, PENG LSV wants to be the value-driven partner that propels game-changing innovation.

Apr 2019 - Present

Co-Founder & Board Member

Current

Irvine, California, Us

IACTA Pharmaceuticals was established with a team of former Allergan executives to develop and commercialize innovative eyecare products. The Company is dedicated to treating diseases, advancing technology and improving patient outcomes. It currently has two Phase 2 and two pre-clinical assets in its pipeline.

Jan 2017 - Present

Member, Board Of Directors

Just C, Inc.

Just C is the marketer of health drinks and gummies, ARYA (aryaforlife.com). ARYA is the brand for low calorie drinks and gummies with the active ingredient (Curcumin) extracted from turmeric with well-established anti-inflammatory and antioxidant properties. The newly developed form of Curcumin (patented) can be easily dissolved in water, is highly absorbable (27x more than regular Curcumin) and is tasteless which makes it ideal to be used in food and beverages.

Jun 2016 - Aug 2020

Board Member

Inflammatory Response Research, Inc (IRR) is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions, including the common cold, traumatic brain injury, and acute radiation syndrome.

May 2019 - Apr 2020

Co-Founder And President, Operations

Scilex Pharmaceuticals, Inc.

Scilex Pharmaceuticals is a privately-held biotech company focused on acquiring, developing and commercializing products for the treatment of pain.Co-founded the company with the intent of finding late-stage opportunities that we could obtain FDA approval for and launch. Key accomplishments:1. In-licensed the rights to a next-generation lidocaine patch from Japanese partners2. Raised ~$20 million to support development3. Sold the company for $70 million to a larger pharmaceutical company 4. Obtained approval for ZTlido(R) (lidocaine topical system) 1.8%5. Raised $140 million to support commercialization through Morgan Stanley6. Helped build a 150 person organization to launch ZTlido (R) (lidocaine topical system) 1.8%As President, Operations, I was responsible for all matters related to Legal, Compliance, Medical Affairs, Research & Development, Supply and Logistics and Quality.

Feb 2014 - Apr 2019

Shareholder

Tulsa, Oklahoma, Us

• Shareholder at a full-service business law firm with more than 125 attorneys practicing in Oklahoma, Arkansas and Washington, D.C. • Represent life science (pharmaceutical, biotech and medical device) and other industry clients in various corporate matters including M&A, SEC, healthcare compliance, FDA regulatory, financings and corporate governance

Jun 2013 - Feb 2014

Partner

Phoenix, Az, Us

Leader in the Bioscience & Healthcare Practice Group • Partner at a full-service business law firm with more than 400 attorneys practicing throughout the southwestern United States and Mexico• Represent life science (pharmaceutical, biotech and medical device) and other industry clients in various corporate matters including M&A, SEC, healthcare compliance, FDA regulatory, financings and corporate governance• Represented a private medical marketing company in the sale of its business • Represented a private medical device company in a corporate reorganization to position itself for a future financing transaction• Represented a controlling stockholder in the acquisition of the remaining stock of a private auto parts company• Represent a controlling stockholder in the sale of his stock in a private U.S. telecommunications company and its European subsidiary• Represent several private biotech startups in corporate formation, capital finance and regulatory and clinical development strategy• Member of the Promotional Review Committee for a public pharmaceutical company tasked with reviewing and approving all promotional materials

Feb 2012 - Jun 2013

Partner

San Francisco, Ca, Us

Co-Chair of the National Life Sciences Practice Group• Partner with a national AM LAW 155 law firm• Started the life sciences practice group to provide top notch legal services to life science companies in a cost-effective manner• Represented life science and other industry clients in various corporate matters including M&A, SEC, healthcare compliance, FDA regulatory affairs, financings, proxy contests and corporate governance• Provided FDA regulatory advice on various commercial initiatives to ensure corporate compliance with FDA regulations• Structures, drafted and negotiated contracts including commercial, operating, supply, employment, IT, indemnification, consulting and confidentiality agreements • Provided counsel and reviewed and drafted documents for investor-led takeover of the Board of Directors of a privately-held medical device company• Corporate Secretary for and attended Board of Director meetings of a privately-held medical device company• Drafted and reviewed securities offering documents for various types of offerings (equity, debt, etc.) • Provided litigation support on corporate M&A and offering matters

Jan 2011 - Feb 2012

Life Science Advisor

William Pedranti, Esq.

• Engaged to assist a small biotech company in establishing a commercial infrastructure to prepare for the launch of the company’s first commercial product• Provided the executive team and senior management members with both business and legal advice on issues that impact various areas of the business• Assisted with the review and drafting of the corporate compliance program, commercial compliance policies and standard operating procedures• Structured, drafted and negotiated contracts including commercial, wholesale, distribution, employment, IT, consulting and confidentiality agreements • Member of the Promotional Review Committee tasked with reviewing and approving all promotional materials• Provided legal advice regarding reimbursement issues including payment assistance programs• Reviewed SEC documents including Form 10-Q and 8-Ks• Managed outside counsel on a range of subject matters including corporate, regulatory and employment issues• Provided FDA regulatory advice on various commercial initiatives to ensure corporate compliance with FDA regulations• Provided commercial compliance training to the commercial team including sales representatives and their managers

May 2010 - Jan 2011

Vice President, General Counsel; Member Of The Executive Committee

Lake Forest, Illinois, Us

Leadership• Member of the Company’s executive team that set and the Company’s strategy and annual goals and oversaw execution of the strategy and goals• During tenure, the Company launched it first two commercial products• The Company was ranked #22 Fastest Growing Company in North America on Deloitte's 2009 Technology Fast 500™• Built the legal department from the ground up; members of the legal department consistently got recognized for outstanding performance • Served as the Company’s Compliance Officer overseeing all areas of compliance for the Company• Member of the Board of Directors of OncoRx Pharma Private Limited, a subsidiary• Managed outside counsel on a range of subject matters including litigation, intellectual property, regulatory, employment and insurance issues• Established alternative fee structures with outside counsel saving the Company money• Established outside counsel review program in order to obtain better, more cost effective serviceTransactional• Lead counsel on equity financing transactions that raised over $200 million• Lead counsel on in-licensing or acquisitions of 8 drug products, including one marketed product• Lead counsel on sale and licensing agreements that generated over $65 million upfront. • Structured, drafted and negotiated merger, asset sale and purchase, license, supply, commercial, partnership, distribution, co-promotion, clinical study, material transfer, employment, IT, consulting and confidentiality agreements Corporate Governance and Compliance• Attended Board of Directors and Board Committee meetings and provided advice on various topics including corporate governance• Provided advice on regulatory issues to ensure corporate compliance with FDA regulations • Served on the Promotional Review Committee tasked with reviewing and approving all promotional materialsSEC and Other• Drafted and reviewed all public company filings• Drafted and implemented employee equity plans

Mar 2004 - May 2010

Attorney

Latham & Watkins Llp

Corporate• Performed general company representation, including providing day-to-day legal advice on all aspects of operation and business strategy• Formed new entities• Prepared and implemented equity-based executive compensation plans• Provided counsel regarding compliance with SEC and Nasdaq corporate governance standards including the drafting and filing of periodic securities and regulatory reports, confidential treatment requests and registrations statements• Represented acquirers and target companies in various types of mergers and acquisitions as well as companies in securities offerings which included handling all aspects of such transactions such as drafting and negotiating asset purchase agreements, merger agreements, securities purchase agreements, registration right agreements, certificates of designation, forms of indenture, warrants and legal opinionsReal Estate• Drafted documents related to the sale of real property including purchase agreements, promissory notes and deeds• Drafted limited liability company operating agreements for real estate clientsLitigation• Handled various aspects of pre-trial discovery, including preparing discovery motions, propounding and responding to discovery, and drafting legal memoranda and other pleadings• Represented indigent clients on a pro bono basis for various family law matters including obtaining temporary restraining orders, custody orders and divorce settlements• Engaged in settlement negotiations; participated in hearings in state court; and represented victims in criminal matters

Sep 2000 - Mar 2004
2 education records

William Pedranti education

Jd, Law

Georgetown University Law Center

Bs, Business Entrepreneurship

University Of Southern California
FAQ

Frequently asked questions about William Pedranti

Quick answers generated from the profile data available on this page.

What company does William Pedranti work for?

William Pedranti works for Visgenx.

What is William Pedranti's role at Visgenx?

William Pedranti is listed as Chief Executive Officer at Visgenx.

What is William Pedranti's email address?

AeroLeads has found 1 work email signal at @scilexpharma.com for William Pedranti at Visgenx.

What is William Pedranti's phone number?

AeroLeads has found 15 phone signal(s) with area code 949, 202, 714, 760, 310, 610, 484 for William Pedranti at Visgenx.

Where is William Pedranti based?

William Pedranti is based in Ladera Ranch, California, United States while working with Visgenx.

What companies has William Pedranti worked for?

William Pedranti has worked for Visgenx, Peng Life Science Ventures, Iacta Pharmaceuticals, Just C, Inc., and Inflammatory Response Research, Inc..

How can I contact William Pedranti?

You can use AeroLeads to view verified contact signals for William Pedranti at Visgenx, including work email, phone, and LinkedIn data when available.

What schools did William Pedranti attend?

William Pedranti holds Jd, Law from Georgetown University Law Center.

What skills is William Pedranti known for?

William Pedranti is listed with skills including Mergers And Acquisitions, Intellectual Property, Licensing, Corporate Governance, Corporate Law, Start Ups, Biotechnology, and Due Diligence.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.